MINOIA, Mariella
 Distribuzione geografica
Continente #
NA - Nord America 3.032
AS - Asia 1.503
EU - Europa 841
SA - Sud America 244
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 27
OC - Oceania 2
Totale 5.677
Nazione #
US - Stati Uniti d'America 2.970
SG - Singapore 553
CN - Cina 400
DE - Germania 202
VN - Vietnam 202
BR - Brasile 184
UA - Ucraina 134
HK - Hong Kong 104
GB - Regno Unito 101
FI - Finlandia 100
TR - Turchia 89
IT - Italia 83
FR - Francia 61
SE - Svezia 43
RU - Federazione Russa 42
JP - Giappone 33
IN - India 29
CA - Canada 28
BD - Bangladesh 25
AR - Argentina 21
MX - Messico 18
AT - Austria 13
ZA - Sudafrica 13
IQ - Iraq 11
ES - Italia 10
PL - Polonia 10
EC - Ecuador 9
ID - Indonesia 9
LT - Lituania 9
NL - Olanda 9
CO - Colombia 8
PK - Pakistan 8
VE - Venezuela 8
BE - Belgio 6
UZ - Uzbekistan 6
CL - Cile 5
AL - Albania 4
EG - Egitto 4
JM - Giamaica 4
LB - Libano 4
PY - Paraguay 4
CR - Costa Rica 3
DZ - Algeria 3
JO - Giordania 3
MY - Malesia 3
UY - Uruguay 3
AZ - Azerbaigian 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
EU - Europa 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
IE - Irlanda 2
KE - Kenya 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
SA - Arabia Saudita 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CY - Cipro 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PE - Perù 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
Totale 5.652
Città #
Singapore 397
Ashburn 382
Woodbridge 247
San Jose 244
Chandler 184
Fairfield 178
Houston 176
Jacksonville 148
Santa Clara 132
Beijing 117
Hong Kong 102
Wilmington 82
Ann Arbor 81
Ho Chi Minh City 74
Seattle 74
Munich 66
Cambridge 64
Council Bluffs 57
Los Angeles 53
Addison 47
Izmir 42
New York 41
Hanoi 39
Helsinki 38
Nanjing 37
Dallas 34
Tokyo 33
Turku 33
Princeton 30
Shanghai 30
Dearborn 27
Lauterbourg 27
São Paulo 26
Boardman 25
Bremen 23
Milan 21
Ferrara 20
Orem 19
Buffalo 18
Shenyang 16
London 15
Nuremberg 14
Brooklyn 13
Chennai 13
Denver 13
Jinan 13
Nanchang 13
Changsha 12
Mexico City 12
San Diego 12
Atlanta 11
Tianjin 11
Da Nang 10
Johannesburg 10
Warsaw 10
Phoenix 9
Chicago 8
Falls Church 8
Poplar 8
Frankfurt am Main 7
Haiphong 7
Hebei 7
Manchester 7
Montreal 7
Mountain View 7
Stockholm 7
Toronto 7
Amsterdam 6
Ankara 6
Boston 6
Brussels 6
Indiana 6
Moscow 6
Washington 6
Auburn Hills 5
Belo Horizonte 5
Caracas 5
Guangzhou 5
Hải Dương 5
Jiaxing 5
Kunming 5
Miami 5
New Delhi 5
Norwalk 5
Orange 5
Piscataway 5
Baghdad 4
Barnet 4
Hefei 4
Jakarta 4
Medellín 4
Newark 4
Ningbo 4
Osasco 4
Paris 4
Quito 4
Rome 4
San Francisco 4
Secaucus 4
Tappahannock 4
Totale 3.913
Nome #
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 291
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 259
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 253
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 238
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 224
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 222
Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids 221
Growth hormone induces chemoresistance in breast cancer cells 220
Growth hormone excess promotes breast cancer chemoresistance 219
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 216
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 199
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 196
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 194
Effects of mTOR inhibitors in the control of non functioning pituitary adenomas cell growth 193
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 192
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 186
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 184
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 183
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 182
Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-κB 178
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 171
Evaluation of PKC isoforms expression in thyroid cells lines and effects of a PKC beta II selective inhibitor 167
GH protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells 159
mTOR inhibition influences cell viability of human bronchial carcinoids in vitro 157
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function. 155
mTOR inhibitors hamper cell viability in selected human medullary thyroid carcinoma primary cultures 153
mTOR inhibition influences cell viability of medullary thyroid carcinoma primary cultures 146
mTOR inhibition hampers cell viability in selected human medullary thyroid carcinoma primary cultures 121
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C  114
null 44
null 40
Totale 5.677
Categoria #
all - tutte 24.893
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.893


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022246 0 0 13 2 8 18 14 6 6 29 41 109
2022/2023387 33 41 18 55 64 52 20 26 48 4 12 14
2023/2024209 15 16 8 6 18 37 8 53 5 2 2 39
2024/2025797 16 9 50 18 100 120 17 17 111 82 115 142
2025/20262.148 209 109 167 260 385 139 282 101 209 194 75 18
2026/2027189 34 97 58 0 0 0 0 0 0 0 0 0
Totale 5.677